Amakem
Diepenbeek
About Amakem
Amakem is a kinase platform company focusing on ophthalmology and is developing new treatments for serious eye conditions. Amakem's product pipeline is based on its unique ‘Localized Drug Action' platform which is designed to generate safe and effective novel kinase inhibitors that minimize systemic exposure with the aim of reducing side effects.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $25.2M
- Funding stage: Early Stage Venture
- Last round: Grant (Jan 2013)
- Website: amakem.com
- Phone: 32-(0)-11-286-982
Industries & Categories
Biotechnology, Medical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/amakem-2698955 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.